Korea Launches Inter-agency Body To Stimulate Local R&D, Earmarks $440 Million For Program
This article was originally published in PharmAsia News
SEOUL - The Korean government has set up an inter-ministry team to support local pharmaceutical companies develop globally competitive drugs. The team will offer R&D training for companies looking to diversify their generic pipelines with innovative products as well as some of the start-up cash needed for new R&D programs
You may also be interested in...
As some local biosimilar firms such as Celltrion have already got their feet firmly on the ground, the South Korean government is now shifting its strategic focus to support for stem cell and gene therapy ventures to help them advance into a global market where no clear leader has yet emerged.
SINGAPORE - Dorairajan Balasubramanian, the secretary-general of the Academy of Sciences for the Developing World, sees opportunities for setting up a Pan-Asian Academy of Sciences to train and support researchers to develop indigenously sourced novel products